In B-ALL, previous studies have shown a heterogeneous and subtype-specific expression pattern of CD9 [15, 16] while subsequent investigations showed its enrichment in leukemia-initiating cells [17–19] and involvement in leukemia dissemination [20]. This evidence concerns the gene CD9 and precursor B-cell acute lymphoblastic leukemia.